Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ERAS |
---|---|---|
09:32 ET | 10383 | 2.37 |
09:34 ET | 6098 | 2.39 |
09:36 ET | 4409 | 2.43 |
09:38 ET | 2200 | 2.425 |
09:39 ET | 4100 | 2.43 |
09:41 ET | 578 | 2.4415 |
09:43 ET | 4450 | 2.45 |
09:45 ET | 1440 | 2.44 |
09:48 ET | 1056 | 2.435 |
09:50 ET | 2900 | 2.435 |
09:52 ET | 6937 | 2.43 |
09:56 ET | 4697 | 2.435 |
09:57 ET | 500 | 2.435 |
09:59 ET | 1718 | 2.43 |
10:01 ET | 2808 | 2.45 |
10:03 ET | 4585 | 2.425 |
10:06 ET | 1712 | 2.435 |
10:08 ET | 800 | 2.43 |
10:10 ET | 1444 | 2.43 |
10:12 ET | 4415 | 2.425 |
10:14 ET | 441 | 2.43 |
10:15 ET | 13424 | 2.42 |
10:17 ET | 1099 | 2.425 |
10:19 ET | 2920 | 2.435 |
10:21 ET | 1557 | 2.425 |
10:24 ET | 200 | 2.425 |
10:26 ET | 1390 | 2.43 |
10:28 ET | 1904 | 2.435 |
10:30 ET | 1178 | 2.44 |
10:32 ET | 7235 | 2.435 |
10:33 ET | 1900 | 2.425 |
10:35 ET | 602 | 2.425 |
10:37 ET | 5222 | 2.42 |
10:39 ET | 500 | 2.4101 |
10:42 ET | 300 | 2.41 |
10:44 ET | 100 | 2.41 |
10:46 ET | 2553 | 2.4 |
10:48 ET | 13447 | 2.3993 |
10:50 ET | 4431 | 2.405 |
10:53 ET | 8453 | 2.4 |
10:55 ET | 200 | 2.39 |
10:57 ET | 1984 | 2.395 |
11:00 ET | 7353 | 2.4 |
11:02 ET | 2927 | 2.42 |
11:04 ET | 100 | 2.415 |
11:06 ET | 100 | 2.41 |
11:08 ET | 4014 | 2.405 |
11:09 ET | 1300 | 2.41 |
11:11 ET | 100 | 2.41 |
11:13 ET | 200 | 2.418 |
11:15 ET | 6696 | 2.41 |
11:18 ET | 1086 | 2.41 |
11:22 ET | 3062 | 2.405 |
11:24 ET | 500 | 2.4 |
11:26 ET | 613 | 2.405 |
11:27 ET | 1000 | 2.4 |
11:29 ET | 6053 | 2.395 |
11:31 ET | 9496 | 2.38 |
11:33 ET | 300 | 2.39 |
11:36 ET | 1400 | 2.38 |
11:38 ET | 3385 | 2.38 |
11:40 ET | 800 | 2.37 |
11:42 ET | 1500 | 2.3748 |
11:44 ET | 400 | 2.375 |
11:45 ET | 2906 | 2.375 |
11:47 ET | 1600 | 2.378 |
11:49 ET | 3430 | 2.385 |
11:51 ET | 1500 | 2.38 |
11:54 ET | 200 | 2.38 |
11:56 ET | 100 | 2.38 |
11:58 ET | 300 | 2.385 |
12:00 ET | 1798 | 2.385 |
12:02 ET | 6030 | 2.39 |
12:03 ET | 100 | 2.385 |
12:05 ET | 200 | 2.39 |
12:07 ET | 200 | 2.385 |
12:09 ET | 18678 | 2.385 |
12:12 ET | 100 | 2.38 |
12:14 ET | 3165 | 2.375 |
12:16 ET | 100 | 2.375 |
12:18 ET | 2060 | 2.37 |
12:20 ET | 100 | 2.375 |
12:21 ET | 2649 | 2.375 |
12:23 ET | 200 | 2.37 |
12:25 ET | 100 | 2.37 |
12:27 ET | 108 | 2.375 |
12:30 ET | 1135 | 2.375 |
12:32 ET | 300 | 2.375 |
12:34 ET | 100 | 2.375 |
12:36 ET | 14275 | 2.375 |
12:38 ET | 100 | 2.375 |
12:41 ET | 300 | 2.375 |
12:45 ET | 200 | 2.375 |
12:48 ET | 300 | 2.37 |
12:50 ET | 3139 | 2.365 |
12:52 ET | 100 | 2.365 |
12:54 ET | 100 | 2.365 |
12:57 ET | 420 | 2.365 |
12:59 ET | 100 | 2.37 |
01:01 ET | 1019 | 2.37 |
01:03 ET | 1300 | 2.37 |
01:06 ET | 300 | 2.37 |
01:08 ET | 625 | 2.365 |
01:10 ET | 5640 | 2.375 |
01:12 ET | 800 | 2.38 |
01:14 ET | 9034 | 2.37 |
01:15 ET | 611 | 2.365 |
01:17 ET | 400 | 2.365 |
01:21 ET | 4060 | 2.355 |
01:24 ET | 4234 | 2.364 |
01:26 ET | 300 | 2.365 |
01:32 ET | 110 | 2.365 |
01:33 ET | 400 | 2.37 |
01:35 ET | 1133 | 2.37 |
01:37 ET | 100 | 2.37 |
01:39 ET | 200 | 2.365 |
01:42 ET | 10190 | 2.355 |
01:44 ET | 739 | 2.3403 |
01:46 ET | 400 | 2.345 |
01:48 ET | 2595 | 2.335 |
01:51 ET | 81307 | 2.35 |
01:53 ET | 9241904 | 2.37 |
01:55 ET | 1100 | 2.365 |
01:57 ET | 7743 | 2.365 |
02:00 ET | 1216 | 2.365 |
02:02 ET | 999 | 2.37 |
02:04 ET | 49022 | 2.42 |
02:06 ET | 1278 | 2.43 |
02:08 ET | 26225 | 2.425 |
02:09 ET | 80990 | 2.45 |
02:11 ET | 7001 | 2.435 |
02:13 ET | 32490 | 2.425 |
02:15 ET | 1469 | 2.435 |
02:18 ET | 1950 | 2.445 |
02:20 ET | 2350 | 2.445 |
02:22 ET | 1300 | 2.445 |
02:24 ET | 12359 | 2.445 |
02:26 ET | 2064 | 2.44 |
02:27 ET | 10877 | 2.44 |
02:29 ET | 390 | 2.44 |
02:31 ET | 7750 | 2.44 |
02:33 ET | 6501 | 2.45 |
02:36 ET | 7941 | 2.445 |
02:38 ET | 610 | 2.44 |
02:40 ET | 5930 | 2.455 |
02:42 ET | 21355 | 2.445 |
02:45 ET | 7160 | 2.44 |
02:47 ET | 300 | 2.445 |
02:49 ET | 3354 | 2.455 |
02:51 ET | 8061 | 2.45 |
02:54 ET | 1754 | 2.45 |
02:56 ET | 10563 | 2.445 |
02:58 ET | 4692 | 2.445 |
03:00 ET | 2400 | 2.445 |
03:02 ET | 1148 | 2.445 |
03:03 ET | 2504 | 2.445 |
03:05 ET | 1689 | 2.44 |
03:07 ET | 952 | 2.445 |
03:09 ET | 1829 | 2.445 |
03:12 ET | 1231 | 2.445 |
03:14 ET | 13809 | 2.445 |
03:16 ET | 9632 | 2.445 |
03:18 ET | 6100 | 2.46 |
03:20 ET | 23794 | 2.465 |
03:21 ET | 6181 | 2.465 |
03:23 ET | 20984 | 2.455 |
03:25 ET | 537 | 2.46 |
03:27 ET | 1200 | 2.455 |
03:30 ET | 12627 | 2.455 |
03:32 ET | 14926 | 2.4525 |
03:34 ET | 1660 | 2.455 |
03:36 ET | 3900 | 2.455 |
03:38 ET | 5220 | 2.455 |
03:39 ET | 10159 | 2.455 |
03:41 ET | 2741 | 2.455 |
03:43 ET | 7859 | 2.455 |
03:45 ET | 17018 | 2.45 |
03:48 ET | 3315 | 2.45 |
03:50 ET | 1712 | 2.45 |
03:52 ET | 24133 | 2.45 |
03:54 ET | 13936 | 2.45 |
03:56 ET | 32182 | 2.445 |
03:57 ET | 17792 | 2.445 |
03:59 ET | 39740 | 2.44 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Erasca Inc | 561.6M | -2.9x | --- |
Savara Inc | 556.9M | -12.1x | --- |
Humacyte Inc | 571.6M | -5.3x | --- |
Celcuity Inc | 575.0M | -6.0x | --- |
Mineralys Therapeutics Inc | 580.9M | -5.6x | --- |
Third Harmonic Bio Inc | 532.3M | -17.2x | --- |
Erasca, Inc. is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The Company has assembled a wholly owned or controlled RAS/MAPK pathway-focused pipeline in the industry, which is focused on modality-agnostic programs aligned with its three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes three clinical-stage programs, such as a pan-RAF inhibitor, an ERK inhibitor, and a central nervous system (CNS)-penetrant EGFR inhibitor, and additional discovery-stage programs targeting other key oncogenic drivers. Its lead product candidate is naporafenib, a pan-RAF inhibitor with the potential for patients with NRAS-mutated (NRASm) melanoma, RAS Q61X solid tumors, and other RAS/MAPK pathway-driven tumors.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $561.6M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 238.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.84 |
Book Value | $2.10 |
P/E Ratio | -2.9x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.